[HTML][HTML] The role of cytokines and chemokines in severe acute respiratory syndrome coronavirus 2 infections
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in countless
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …
[HTML][HTML] COVID-19-related mortality risk in people with severe mental illness: a systematic and critical review
M De Hert, V Mazereel, M Stroobants… - Frontiers in …, 2022 - frontiersin.org
Background: Increasing clinical evidence suggests that people with severe mental illness
(SMI), including schizophrenia spectrum disorders, bipolar disorder (BD), and major …
(SMI), including schizophrenia spectrum disorders, bipolar disorder (BD), and major …
[HTML][HTML] Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches
IA Savin, MA Zenkova, AV Sen'kova - International Journal of Molecular …, 2022 - mdpi.com
Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …
[HTML][HTML] Mitochondrial dynamics in SARS-COV2 spike protein treated human microglia: implications for neuro-COVID
E Clough, J Inigo, D Chandra, L Chaves… - Journal of Neuroimmune …, 2021 - Springer
Emerging clinical data from the current COVID-19 pandemic suggests that~ 40% of COVID-
19 patients develop neurological symptoms attributed to viral encephalitis while in COVID …
19 patients develop neurological symptoms attributed to viral encephalitis while in COVID …
[HTML][HTML] Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation
C Zhang, X Wang, C Wang, C He, Q Ma, J Li… - Frontiers in …, 2021 - frontiersin.org
Background: Acute lung injury (ALI) is characterized by dysfunction of the alveolar epithelial
membrane caused by acute inflammation and tissue injury. Qingwenzhike (QWZK) …
membrane caused by acute inflammation and tissue injury. Qingwenzhike (QWZK) …
[HTML][HTML] From infection to immunity: understanding the response to SARS-CoV2 through in-silico modeling
Background Immune system conditions of the patient is a key factor in COVID-19 infection
survival. A growing number of studies have focused on immunological determinants to …
survival. A growing number of studies have focused on immunological determinants to …
[HTML][HTML] Dynamics of inflammatory markers in predicting mortality in COVID-19
Methods We conducted a retrospective study of 142 patients admitted with COVID-19 in the
Department of Medicine at All India Institute of Medical Sciences, New Delhi, from May 2021 …
Department of Medicine at All India Institute of Medical Sciences, New Delhi, from May 2021 …
[HTML][HTML] Role of innate and adaptive cytokines in the survival of COVID-19 patients
J Monserrat, A Gómez-Lahoz, MA Ortega… - International journal of …, 2022 - mdpi.com
SARS-CoV-2 is a new coronavirus characterized by a high infection and transmission
capacity. A significant number of patients develop inadequate immune responses that …
capacity. A significant number of patients develop inadequate immune responses that …
Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID‐19 Patients
Background. Tissue damage caused by COVID‐19 could be detected by several clinical
indicators including hematological, immunological, biochemical, and inflammatory markers …
indicators including hematological, immunological, biochemical, and inflammatory markers …
[HTML][HTML] Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium
RK Gupta, EL Nwachuku, BE Zusman, RM Jha… - Plos one, 2021 - journals.plos.org
Drug repurposing has the potential to bring existing de-risked drugs for effective intervention
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …
in an ongoing pandemic—COVID-19 that has infected over 131 million, with 2.8 million …